246 related articles for article (PubMed ID: 29554222)
1. The Association of Arsenic Exposure and Arsenic Metabolism With the Metabolic Syndrome and Its Individual Components: Prospective Evidence From the Strong Heart Family Study.
Spratlen MJ; Grau-Perez M; Best LG; Yracheta J; Lazo M; Vaidya D; Balakrishnan P; Gamble MV; Francesconi KA; Goessler W; Cole SA; Umans JG; Howard BV; Navas-Acien A
Am J Epidemiol; 2018 Aug; 187(8):1598-1612. PubMed ID: 29554222
[TBL] [Abstract][Full Text] [Related]
2. Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study.
Spratlen MJ; Grau-Perez M; Umans JG; Yracheta J; Best LG; Francesconi K; Goessler W; Balakrishnan P; Cole SA; Gamble MV; Howard BV; Navas-Acien A
Environ Int; 2018 Dec; 121(Pt 1):728-740. PubMed ID: 30321848
[TBL] [Abstract][Full Text] [Related]
3. Targeted metabolomics to understand the association between arsenic metabolism and diabetes-related outcomes: Preliminary evidence from the Strong Heart Family Study.
Spratlen MJ; Grau-Perez M; Umans JG; Yracheta J; Best LG; Francesconi K; Goessler W; Bottiglieri T; Gamble MV; Cole SA; Zhao J; Navas-Acien A
Environ Res; 2019 Jan; 168():146-157. PubMed ID: 30316100
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study.
Kuo CC; Howard BV; Umans JG; Gribble MO; Best LG; Francesconi KA; Goessler W; Lee E; Guallar E; Navas-Acien A
Diabetes Care; 2015 Apr; 38(4):620-7. PubMed ID: 25583752
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study.
Newman JD; Navas-Acien A; Kuo CC; Guallar E; Howard BV; Fabsitz RR; Devereux RB; Umans JG; Francesconi KA; Goessler W; Best LT; Tellez-Plaza M
Am J Epidemiol; 2016 Dec; 184(11):806-817. PubMed ID: 27810857
[TBL] [Abstract][Full Text] [Related]
6. Metals and risk of incident metabolic syndrome in a prospective cohort of midlife women in the United States.
Wang X; Karvonen-Gutierrez CA; Herman WH; Mukherjee B; Park SK
Environ Res; 2022 Jul; 210():112976. PubMed ID: 35202625
[TBL] [Abstract][Full Text] [Related]
7. Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.
Kaufman JA; Mattison C; Fretts AM; Umans JG; Cole SA; Voruganti VS; Goessler W; Best LG; Zhang Y; Tellez-Plaza M; Navas-Acien A; Gribble MO
Environ Res; 2021 Apr; 195():110864. PubMed ID: 33581093
[TBL] [Abstract][Full Text] [Related]
8. Association of Low-Moderate Arsenic Exposure and Arsenic Metabolism with Incident Diabetes and Insulin Resistance in the Strong Heart Family Study.
Grau-Perez M; Kuo CC; Gribble MO; Balakrishnan P; Jones Spratlen M; Vaidya D; Francesconi KA; Goessler W; Guallar E; Silbergeld EK; Umans JG; Best LG; Lee ET; Howard BV; Cole SA; Navas-Acien A
Environ Health Perspect; 2017 Dec; 125(12):127004. PubMed ID: 29373862
[TBL] [Abstract][Full Text] [Related]
9. The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.
Zheng LY; Umans JG; Yeh F; Francesconi KA; Goessler W; Silbergeld EK; Bandeen-Roche K; Guallar E; Howard BV; Weaver VM; Navas-Acien A
Epidemiology; 2015 Jul; 26(4):601-12. PubMed ID: 25929811
[TBL] [Abstract][Full Text] [Related]
10. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
[TBL] [Abstract][Full Text] [Related]
11. Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study.
Gribble MO; Howard BV; Umans JG; Shara NM; Francesconi KA; Goessler W; Crainiceanu CM; Silbergeld EK; Guallar E; Navas-Acien A
Am J Epidemiol; 2012 Nov; 176(10):865-74. PubMed ID: 23097256
[TBL] [Abstract][Full Text] [Related]
12. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study.
Moon KA; Guallar E; Umans JG; Devereux RB; Best LG; Francesconi KA; Goessler W; Pollak J; Silbergeld EK; Howard BV; Navas-Acien A
Ann Intern Med; 2013 Nov; 159(10):649-59. PubMed ID: 24061511
[TBL] [Abstract][Full Text] [Related]
13. Associations between blood and urinary manganese with metabolic syndrome and its components: Cross-sectional analysis of National Health and Nutrition Examination Survey 2011-2016.
Lo K; Yang JL; Chen CL; Liu L; Huang YQ; Feng YQ; Yang AM
Sci Total Environ; 2021 Aug; 780():146527. PubMed ID: 33774283
[TBL] [Abstract][Full Text] [Related]
14. Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.
Gribble MO; Crainiceanu CM; Howard BV; Umans JG; Francesconi KA; Goessler W; Zhang Y; Silbergeld EK; Guallar E; Navas-Acien A
Environ Health; 2013 Dec; 12():107. PubMed ID: 24321145
[TBL] [Abstract][Full Text] [Related]
15. Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians.
Kim NH; Mason CC; Nelson RG; Afton SE; Essader AS; Medlin JE; Levine KE; Hoppin JA; Lin C; Knowler WC; Sandler DP
Am J Epidemiol; 2013 May; 177(9):962-9. PubMed ID: 23504692
[TBL] [Abstract][Full Text] [Related]
16. Low-moderate arsenic exposure and respiratory in American Indian communities in the Strong Heart Study.
Powers M; Sanchez TR; Grau-Perez M; Yeh F; Francesconi KA; Goessler W; George CM; Heaney C; Best LG; Umans JG; Brown RH; Navas-Acien A
Environ Health; 2019 Nov; 18(1):104. PubMed ID: 31779614
[TBL] [Abstract][Full Text] [Related]
17. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study.
Navas-Acien A; Umans JG; Howard BV; Goessler W; Francesconi KA; Crainiceanu CM; Silbergeld EK; Guallar E
Environ Health Perspect; 2009 Sep; 117(9):1428-33. PubMed ID: 19750109
[TBL] [Abstract][Full Text] [Related]
18. Environmental polycyclic aromatic hydrocarbon exposure in relation to metabolic syndrome in US adults.
Yang X; Xue Q; Wen Y; Huang Y; Wang Y; Mahai G; Yan T; Liu Y; Rong T; Wang Y; Chen D; Zeng S; Yang CX; Pan XF
Sci Total Environ; 2022 Sep; 840():156673. PubMed ID: 35700788
[TBL] [Abstract][Full Text] [Related]
19. Associations of maternal arsenic exposure with adult fasting glucose and insulin resistance in the Strong Heart Study and Strong Heart Family Study.
Tinkelman NE; Spratlen MJ; Domingo-Relloso A; Tellez-Plaza M; Grau-Perez M; Francesconi KA; Goessler W; Howard BV; MacCluer J; North KE; Umans JG; Factor-Litvak P; Cole SA; Navas-Acien A
Environ Int; 2020 Apr; 137():105531. PubMed ID: 32059145
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and incident depressive symptoms in young and middle-aged adults: A cohort study.
Jeon SW; Lim SW; Shin DW; Ryu S; Chang Y; Kim SY; Oh KS; Shin YC; Kim YH
J Affect Disord; 2019 Mar; 246():643-651. PubMed ID: 30611062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
